New Pharmaceutical Registrations in Rwanda: June 2026 Insights
AfriReg data reveals 40 new pharma registrations in Rwanda in June 2026, primarily veterinary products. Discover key players and therapeutic trends.
AfriReg's latest intelligence indicates a significant surge in pharmaceutical product registrations across Africa, with 40 new products added to the regulatory landscape in the last 30 days. This analysis focuses on the registrations recorded in June 2026, all of which occurred in Rwanda, providing a concentrated look at market entry and regulatory activity within this East African nation.
The entire batch of 40 new registrations in June 2026 was filed in Rwanda, a clear signal of focused market expansion efforts by various pharmaceutical manufacturers. Notably, a vast majority of these registrations are for veterinary pharmaceutical products, suggesting a robust and growing animal health sector in Rwanda. This trend could be attributed to several factors, including increasing livestock farming, enhanced animal disease surveillance, or a push for food security initiatives within the country.
Key Players and Their Strategies
An examination of the companies behind these new registrations reveals a competitive yet concentrated landscape. Several international and regional manufacturers are actively expanding their portfolios in Rwanda, with a strong emphasis on veterinary solutions. This indicates a targeted strategy to address the specific needs of the Rwandan agricultural and livestock industries.
The following table details the new registrations, highlighting the products, their holders, and key registration data:
| Drug | Holder | Country | Status | Date Added |
|---|---|---|---|---|
| OXYTETRACYCLINE 50% (OXYTETRACYCLINE HCL 500 MG/G) | VETERINARY & AGRICULTURAL MANUFACTURING CO. LTD (VAPCO) | Rwanda | active | 10 Jun 2026 |
| WORMITA SUSPENSION DEWORMER (ALBENDAZOLE 2.5% W/V) | COSMOS LIMITED | Rwanda | active | 10 Jun 2026 |
| ALBECTIN SUSPENSION (ALBENDAZOLE BP 100 MG/ML, IVERMECTIN BP 2 MG/ML) | ASHISH LIFE SCIENCE PVT LIMITED | Rwanda | active | 10 Jun 2026 |
| ENROSOL-S (ENROFLOXACIN, 100 MG/ML) | VETERINARY & AGRICULTURAL MANUFACTURING CO. LTD (VAPCO) | Rwanda | active | 10 Jun 2026 |
| BUTASAL-100 (BUTAFOSFAN 100 MG/ML AND VITAMIN B12 (CYANOCOBALAMIN) 50 μg/ml) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| ASCAREX WORM POWDER (PIPERAZINE CITRATE 0.35G/G) | COSMOS LIMITED | Rwanda | active | 10 Jun 2026 |
| DOXIN-200WS (DOXYCYCLINE HYCLATE 100MG/G, TYLOSIN TARTRATE 100MG/G) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| VAPCOZINE 12.5% EMULSIFIABLE CONCENTRATES (EC) (AMITRAZ 12.5% EC) | VETERINARY & AGRICULTURAL MANUFACTURING CO. LTD (VAPCO) | Rwanda | active | 10 Jun 2026 |
| BUTACURE (BUPARVAQUONE 50 MG/ML) | ASHISH LIFE SCIENCE PVT LIMITED | Rwanda | active | 10 Jun 2026 |
| OXYTETRACYCLINE 25% (OXYTETRACYCLINE HCL 250 MG/G) | VETERINARY & AGRICULTURAL MANUFACTURING | Rwanda | active | 10 Jun 2026 |
| TOLTRACOX (TOLTRAZURIL 50MG/ML) | ASHISH LIFE SCIENCE PVT LIMITED | Rwanda | active | 10 Jun 2026 |
| AMPROLIUM-PLUS (AMPROLIUM HCL 250 MG/G AND ETHOPABATE 16 MG/G) | VETERINARY & AGRICULTURAL MANUFACTURING PRODUCTS CO. LTD (VAPCO) | Rwanda | active | 10 Jun 2026 |
| COLOXAN WS (DOXYCYCLINE HYCLATE, COLISTIN SULFATE 100 MG/G, 1 200 000 IU/G) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| S-DIME SOLUTION (SULFADIMIDINE SODIUM 16% W/W) | COSMOS LIMITED | Rwanda | active | 10 Jun 2026 |
| COMBAT SHAMPOO (PERMETHRIN 0.5 MG/ML, CETRIMIDE 10MG/ML) | VETERINARY AND AGRICULTURAL MANUFACTUR | Rwanda | active | 10 Jun 2026 |
| VITOL-140 (VITAMIN A, RETINOL PALMITATE 80 000 IU/ML, VITAMIN D3, CHOLECALCIFEROL 40 000 IU/ML, VITAMIN E, α-TOCOPHEROL ACETATE 20 MG/ML) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| MILK SALVE (DICHLOROPHEN 0.55%W/W) | CKL AFRICA LTD | Rwanda | active | 10 Jun 2026 |
| ASCAZINE (PIPERAZINE CITRATE 360 MG/G) | VETERINARY & AGRICULTURAL MANUFACTURING CO. LTD (VAPCO) | Rwanda | active | 10 Jun 2026 |
| ASHOXY 20% (OXYTETRACYCLINE HYDROCHLORIDE B.P 200MG/G) | ASHISH LIFE SCIENCE PVT LIMITED | Rwanda | active | 10 Jun 2026 |
| BIOCILLIN-150 LA (AMOXICILLIN BASE 150 MG/ML) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| ASHIALBEN 10% (ALBENDAZOLE BP 500MG PER 5ML) | ASHISH LIFE SCIENCE PVT LIMITED | Rwanda | active | 10 Jun 2026 |
| GENTA-100 (GENTAMICIN BASE 100 MG/ML) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| AMPROLIUM-60 (AMPROLIUM HCL 600MG/G) | VETERINARY AND AGRICULTURAL MANUFACTURING C0. LTD. (VAPCO) | Rwanda | active | 10 Jun 2026 |
| CASTRALGIN (METAMIZOLE SODIUM MONOHYDRATE 500 MG/ML) | — | Rwanda | active | 10 Jun 2026 |
| ALBECTIN (ALBENDAZOLE BP 3000 MG &IVERMECTIN BOLUS 100 MG) | ASHISH LIFE SCIENCE PVT LIMITED | Rwanda | active | 10 Jun 2026 |
| INTERMECTIN (IVERMECTIN 10 MG/ML) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| INTERMECTIN SUPER (IVERMECTIN 10 MG/ML AND CLORSULON 100 MG/ML) | — | Rwanda | active | 10 Jun 2026 |
| PHENYLJECT (PHENYLBUTAZONE 200 MG/ML) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| SULFA-333 (SULFADIMIDINE SODIUM 333 MG/ML) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| DOXY-500 WS (DOXYCYCLINE HYCLATE 500 MG/G) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| ALBENOL-100 ORAL (ALBENDAZOLE, 100 MG/ML) | INTERCHEMIE WERKEN “DE ADELAAR” B.V | Rwanda | active | 10 Jun 2026 |
| NILZASH (OXYCLOZANIDE AND LEVAMISOLE HCL) | ASHISH LIFE SCIENCE PVT LIMITED | Rwanda | active | 10 Jun 2026 |
| NILZASH S FORTE (LEVAMISOLE HCL AND OXYCLOZANIDE) | ASHISH LIFE SCIENCE PVT LIMITED | Rwanda | active | 10 Jun 2026 |
| LIMOXIN-100 (OXYTETRACYCLINE BASE 100 MG/ML) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| GLUCORTIN-20 (DEXAMETHASONE BASE 2 MG/ML) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| BIOSOL WDP (TRIMETHOPRIM BP 20 MG/G & SULPHAMETHOXAZOLE BP 100 MG/G) | VETCARE KENYA LIMITED | Rwanda | active | 10 Jun 2026 |
| INTERFLOX-100 (ENROFLOXACIN 100 MG/ML) | INTERCHEMIE WERKEN “DE ADELAAR” B.V. | Rwanda | active | 10 Jun 2026 |
| LEVOZAN SUSPENSION (LEVAMISOLE HCL + OXYCLOZANIDE 30 MG/ ML + 60 MG/ML) | VETERINARY & AGRICULTURAL MANUFACTURING CO. LTD (VAPCO) | Rwanda | active | 10 Jun 2026 |
| ASHIENRO 10% (ENROFLOXACIN 100 MG/G) | ASHISH LIFE SCIENCE PVT. LIMITED | Rwanda | active | 10 Jun 2026 |
| WORMICID LIQUID DEWORMER (LEVAMISOLE HYDROCHLORIDE 1.5% W/V) | COSMOS LIMITED | Rwanda | active | 10 Jun 2026 |
Therapeutic Area Dominance: Animal Health
The overwhelming majority of newly registered products fall under veterinary pharmaceuticals. This dominance is particularly evident in anti-parasitic agents, antibiotics, and vitamin supplements for animals. Products containing Albendazole, Ivermectin, Oxytetracycline, Enrofloxacin, and Levamisole appear frequently, targeting common parasitic infections, bacterial diseases, and nutritional deficiencies in livestock.
Key Therapeutic Categories:
- Anti-parasitics (Dewormers/Anthelmintics): A significant portion of the registrations are for products combating internal and external parasites, with active ingredients like Albendazole, Ivermectin, Piperazine Citrate, and Levamisole. This indicates a strong focus on livestock health management and productivity.
- Antibiotics: Several new registrations feature broad-spectrum antibiotics such as Oxytetracycline, Doxycycline, Enrofloxacin, Amoxicillin, Gentamicin, and Sulfadimidine, suggesting ongoing efforts to control bacterial infections in animals.
- Vitamins and Nutritional Supplements: Products like VITOL-140 (containing Vitamins A, D3, E) and BUTASAL-100 (Butafosfan and Vitamin B12) highlight the importance placed on animal nutrition and growth promotion.
- Anti-inflammatories/Analgesics: Registrations like CASTRALGIN (Metamizole Sodium Monohydrate) and PHENYLJECT (Phenylbutazone) indicate a need for managing pain and inflammation in veterinary practice.
Market Access Implications for Rwanda
This concentrated wave of veterinary product registrations in Rwanda has several implications for market access and the broader pharmaceutical industry:
- Growing Demand for Animal Health Products: The data strongly signals a booming animal health sector in Rwanda. Manufacturers are responding to existing or anticipated demand, potentially driven by government initiatives, local agricultural growth, and increasing livestock populations.
- Streamlined Regulatory Pathway: The high number of simultaneous registrations from various companies suggests a relatively efficient or at least accessible regulatory pathway for veterinary products in Rwanda. This can attract more players to the market.
- Competitive Landscape: With multiple companies registering similar therapeutic agents (e.g., several Albendazole and Oxytetracycline products), the market for these specific veterinary drugs is becoming more competitive. This could lead to a focus on product differentiation, pricing strategies, and local distribution networks.
- Potential for Human Pharma Growth: While these registrations are primarily veterinary, a strong regulatory framework and increased activity in one sector can lay the groundwork for growth and easier market entry in the human pharmaceutical sector in the future.
Companies Driving the Registrations
Several key players stand out from the registration data:
- Interchemie Werken “De Adelaar” B.V.: This Dutch company is highly active, with numerous registrations for a diverse range of veterinary products, including antibiotics, anti-parasitics, and vitamins. Their robust presence indicates a strategic focus on the African veterinary market.
- Ashish Life Science Pvt Limited: An Indian pharmaceutical company, Ashish Life Science shows a strong commitment to Rwanda's animal health, particularly with anthelmintics (Albendazole, Ivermectin) and antibiotics (Oxytetracycline, Enrofloxacin).
- Veterinary & Agricultural Manufacturing Co. Ltd (VAPCO): A significant regional player, VAPCO has a broad portfolio of veterinary products, from antibiotics to anti-parasitics, demonstrating its strong regional market penetration.
- Cosmos Limited: This East African company is also contributing to the dewormer market, indicating local and regional companies are actively competing with international players.
The concentration of these new registrations in Rwanda highlights the country's growing importance as a market for animal health pharmaceuticals in Africa. For pharmaceutical companies, understanding these trends is crucial for strategic planning, market entry decisions, and competitive positioning.
AfriReg Pro’s advanced regulatory intelligence platform helps pharmaceutical regulatory teams automate the tracking of new product registrations, market authorization updates, and regulatory changes across all African markets, providing real-time insights to inform your market access strategies.